CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) - 6 months ended Apr. 30, 2018 - USD ($) |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Total Shareholders Equity [Member] |
Noncontrolling Interest [Member] |
Total |
---|---|---|---|---|---|---|
Balance at Oct. 31, 2017 | $ 166,028 | $ 163,931,079 | $ (156,174,184) | $ 7,922,923 | $ 7,922,923 | |
Balance (in Shares) at Oct. 31, 2017 | 16,602,759 | |||||
Stock option compensation to employees and directors | 472,532 | 472,532 | 472,532 | |||
Stock option compensation to consultants | 126,151 | 126,151 | 126,151 | |||
Common stock issued upon exercise of stock options | $ 398 | (398) | ||||
Common stock issued upon exercise of stock options (in Shares) | 39,816 | |||||
Common stock issued to consultants | $ 53 | 14,949 | 15,002 | 15,002 | ||
Common stock issued to consultants (in Shares) | 5,347 | |||||
Common stock issued in at-the-market offering | $ 2,025 | 675,345 | 677,370 | 677,370 | ||
Common stock issued in at-the-market offering (in Shares) | 202,523 | |||||
Issuance of noncontrolling interest in Certainty Therapeutics, Inc | 68,974 | 68,974 | $ (4,318) | 64,656 | ||
Net loss | (3,216,606) | (3,216,606) | (41,382) | (3,257,988) | ||
Balance at Apr. 30, 2018 | $ 168,504 | $ 165,288,632 | $ (159,390,790) | $ 6,066,346 | $ (45,700) | $ 6,020,646 |
Balance (in Shares) at Apr. 30, 2018 | 16,850,445 |
X | ||||||||||
- Definition Amount of other increase (decrease) in additional paid in capital (APIC). No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation for stock options. No definition available.
|
X | ||||||||||
- Definition Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. No definition available.
|
X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. No definition available.
|
X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|